Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

GBT021601, a Next Generation HbS Polymerization Inhibitor: Results of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Adults Living with Sickle Cell Disease and Healthy Volunteers

R. Clark Clark Brown, Andrew Redfern, Eleanor Lisbon, Carla Washington, Irene Agodoa, Kim Smith-Whitley

Blood (2021) 138 (Supplement 1): 3099.

DOI: https://doi.org/10.1182/blood-2021-152924

Published: 2021

Journal Articles

Effects of the COVID-19 Pandemic on Caregivers of Young Children with Sickle Cell Disease Enrolled in the Engage-HU Trial

Blood (2021) 138 (Supplement 1): 1891.

DOI: https://doi.org/10.1182/blood-2021-152722

Published: 2021

Journal Articles

National Survey of Pediatric Sickle Cell Providers on Their Contraceptive Practices for Female Patients

Megan Askew, Arlene Smaldone, Melanie A. Gold, Kim Smith-Whitley, John J. Strouse, Zhezhen Jin, Nancy S. Green

Blood (2021) 138 (Supplement 1): 1898.

DOI: https://doi.org/10.1182/blood-2021-154083

Published: 2021

Journal Articles

Pharmacokinetics/Pharmacodynamics, Safety and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease and a History of Vaso-Occlusive Crises: Results from the Phase II, Multicenter, Open-Label Solace-Adults Study

Darla Liles, MD, Kim Smith-Whitley, MD, R Clark Brown, MD PhD, Nirmish Shah, MD, Santosh M Nair, MD, Chiaki Tanaka, PhD, Shankaranand Bodla, Gessami Sanchez-Olle, PhD, Urs Albers, PhD, Julie Kanter, MD

Blood (2020) 136 (Supplement 1): 17–19.

DOI: https://doi.org/10.1182/blood-2020-137434

Published: 2020

Journal Articles

Discordant Beliefs, Perceptions, and Experiences between Patients with Sickle Cell Disease and Their Care Teams: Insights from a Pilot Program to Support Shared Decision-Making

Kim Smith-Whitley, MD, Lewis L. Hsu, MD PhD, Anne Jacobson, MS, Jeffrey D Carter, PhD, Tamar Sapir, PhD

Blood (2020) 136 (Supplement 1): 15–17.

DOI: https://doi.org/10.1182/blood-2020-136742

Published: 2020

Journal Articles

Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study

Nancy S. Green, MD, Deepa Manwani, MD, Kim Smith-Whitley, MD, Banu Aygun, MD, Abena Appiah-Kubi, MD MPH, Arlene Smaldone, PhD CPNP

Blood (2020) 136 (Supplement 1): 41–42.

DOI: https://doi.org/10.1182/blood-2020-140866

Published: 2020

Journal Articles

Addressing Recruitment Challenges in the Engage-HU Trial in Young Children with Sickle Cell Disease

Blood (2020) 136 (Supplement 1): 26–27.

DOI: https://doi.org/10.1182/blood-2020-141471

Published: 2020

Journal Articles

Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease

Anna M Hood, PhD, Yolanda Johnson, MLS, Cara Nwankwo, BA, Lisa M Shook, MA, Aimee K Hildenbrand, PhD, Allison A. King, MD MPH, PhD, Kim Smith-Whitley, MD, Sherif M. Badawy, MD, Alexis A Thompson, MD MPH, Susan E Creary, MD, Connie M. Piccone, MD, Lynne D. Neumayr, Jean L. Raphael, MD MPH, Amber M Yates, MD, Sohail Rana, MD, Steven K Reader, PhD, Emily Riehm Meier, MD MSHS, Amy Sobota, MD MPH, Lori E. Crosby, PhD

Blood (2019) 134 (Supplement_1): 4713.

DOI: https://doi.org/10.1182/blood-2019-124835

Published: 2019

Journal Articles

Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies

Julie Kanter, MD, Darla K Liles, MD, Kim Smith-Whitley, MD, Clark Brown, MD PhD, Abdullah Kutlar, MD, Brian Elliott, Amit Shah, Jeremie Lincy, Susan Poggio, Kenneth I. Ataga, MBBS

Blood (2019) 134 (Supplement_1): 991.

DOI: https://doi.org/10.1182/blood-2019-123965

Published: 2019

Journal Articles

Preclinical Evaluation of ALS20, a New and Improved Lentiviral Vector for Beta-Globinopathies

Laura Breda, PhD, Valentina Ghiaccio, PhD, Silvia Pires Lourenco, MSc, Danuta Jadwiga Jarocha, PhD, Yasuhiro Ikawa, MD PhD, Naoto Tanaka, PhD, Virginia Guzikowski, Carla Casu, PhD, Kim Smith-Whitley, MD, Janet L. Kwiatkowski, MD MSCE, Stefano Rivella, PhD

Blood (2019) 134 (Supplement_1): 2242.

DOI: https://doi.org/10.1182/blood-2019-124043

Published: 2019

Journal Articles

2'-O-Methoxyethyl Splice-Switching Oligos to Reverse Splicing from IVS2-745 β-Thalassemia Patient Cells: A Foundation for Potential Therapies

Blood (2019) 134 (Supplement_1): 2244.

DOI: https://doi.org/10.1182/blood-2019-127017

Published: 2019

Journal Articles

Improved Lentiviral Vectors for the Cure of Hemoglobinopathies

Laura Breda, PhD, Valentina Ghiaccio, PhD, Hanyia Zaidi, Silvia Pires Lourenco, MSc, Carla Casu, Kim Smith-Whitley, MD, Janet L. Kwiatkowski, MD, Vanessa Carrion, RN, CPN, Virginia Guzikowski, RN, MSN, CRNP, Ryo Kurita, PhD, Yukio Nakamura, MD PhD, Stefano Rivella, PhD

Blood (2018) 132 (Supplement 1): 3477.

DOI: https://doi.org/10.1182/blood-2018-99-111319

Published: 2018

Journal Articles

Incidence of Hemolytic Events after Exposure to Triggering Medications in Pediatric Patients with G6PD Deficiency

Bhavya Doshi, MD, Aditi Kamdar, MD, Kim Smith-Whitley, MD, Michele P Lambert, MD MTR, Amrom Obstfeld, MD PhD

Blood (2016) 128 (22): 4810.

DOI: https://doi.org/10.1182/blood.V128.22.4810.4810

Published: 2016

Journal Articles

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial

Karen L. Bride, Tiffaney Vincent, Kim Smith-Whitley, Michele P. Lambert, Jack J. Bleesing, Alix E. Seif, Catherine S. Manno, James Casper, Stephan A. Grupp, David T. Teachey

Blood (2016) 127 (1): 17–28.

DOI: https://doi.org/10.1182/blood-2015-07-657981

Published: 2016

Includes: Supplemental data

Journal Articles

A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children

Blood (2015) 126 (14): 1651–1657.

DOI: https://doi.org/10.1182/blood-2015-05-647107

Published: 2015

Includes: Supplemental data

Journal Articles

A Multi-Center Randomized Controlled Trial of Intravenous Magnesium for Sickle Cell Pain Crisis in Children

Blood (2014) 124 (21): 88.

DOI: https://doi.org/10.1182/blood.V124.21.88.88

Published: 2014

Journal Articles

Reproductive Decisions in Families Affected By Sickle Cell Disease

Corinna L. Schultz, MD MSHP, Trudy Tchume-Johnson, LSW, Tannoa Jackson, BS, Henrietta Enninful-Eghan, RN, MPH, Marilyn Schapira, MD MPH, Kim Smith-Whitley, MD

Blood (2014) 124 (21): 2175.

DOI: https://doi.org/10.1182/blood.V124.21.2175.2175

Published: 2014

Journal Articles

Reproductive issues in sickle cell disease

Kim Smith-Whitley

Blood (2014) 124 (24): 3538–3543.

DOI: https://doi.org/10.1182/blood-2014-07-577619

Published: 2014

Journal Articles

Targeting mTOR Signaling Leads To Complete and Durable Responses In Children With Multi-Lineage Autoimmune Cytopenias, Including ALPS, SLE, Evans and CVID

David T. Teachey, MD, TIffaney Vincent, Kim Smith-Whitley, MD, Michele P Lambert, MD, Alix E. Seif, MD, MPH, James T. Casper, MD, Stephan A Grupp, MD, PhD

Blood (2013) 122 (21): 330.

DOI: https://doi.org/10.1182/blood.V122.21.330.330

Published: 2013

Journal Articles

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

Timothy L. McCavit, MD, MS, Lakshmanan Krishnamurti, MD, Lewis L. Hsu, MD, PhD, Charles T. Quinn, MD, MS, Isaac Odame, MD, Ofelia A. Alvarez, MD, Catherine Driscoll, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Ted Wun, MD, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 2206.

DOI: https://doi.org/10.1182/blood.V122.21.2206.2206

Published: 2013

NARROW

GBT021601, a Next Generation HbS Polymerization Inhibitor: Results of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Adults Living with Sickle Cell Disease and Healthy Volunteers

Effects of the COVID-19 Pandemic on Caregivers of Young Children with Sickle Cell Disease Enrolled in the Engage-HU Trial

National Survey of Pediatric Sickle Cell Providers on Their Contraceptive Practices for Female Patients

Pharmacokinetics/Pharmacodynamics, Safety and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease and a History of Vaso-Occlusive Crises: Results from the Phase II, Multicenter, Open-Label Solace-Adults Study

Discordant Beliefs, Perceptions, and Experiences between Patients with Sickle Cell Disease and Their Care Teams: Insights from a Pilot Program to Support Shared Decision-Making

Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study

Addressing Recruitment Challenges in the Engage-HU Trial in Young Children with Sickle Cell Disease

Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease

Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies

Preclinical Evaluation of ALS20, a New and Improved Lentiviral Vector for Beta-Globinopathies

2'-O-Methoxyethyl Splice-Switching Oligos to Reverse Splicing from IVS2-745 β-Thalassemia Patient Cells: A Foundation for Potential Therapies

Improved Lentiviral Vectors for the Cure of Hemoglobinopathies

Incidence of Hemolytic Events after Exposure to Triggering Medications in Pediatric Patients with G6PD Deficiency

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial

A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children

A Multi-Center Randomized Controlled Trial of Intravenous Magnesium for Sickle Cell Pain Crisis in Children

Reproductive Decisions in Families Affected By Sickle Cell Disease

Reproductive issues in sickle cell disease

Targeting mTOR Signaling Leads To Complete and Durable Responses In Children With Multi-Lineage Autoimmune Cytopenias, Including ALPS, SLE, Evans and CVID

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only